Researchers from the Institute of Cancer Research in London, UK,
describe how they used robotic microscopy and mathematical algorithms -
not unlike the algorithms Facebook uses for facial recognition, to
assess shape and contextual features of hundreds of thousands of cancer cells.
The study highlights the fact that the body's natural defenses are
constantly battling against cancer cells, and there are numerous
strategies on both sides of the fight. Health wins when the balance tips
one way, disease wins when it tips the other way.
The study shows that the physical shape of a cancer cell can be one
of the things that tips the balance in favor of disease, not only by
helping it to evade the immune system but even to the point of helping
it thrive in response to it.
"Our study shows the crucial importance of a breast cancer cell's shape in how it responds to inflammation, with certain shapes more likely to respond to the body's immune system by activating pro-survival signals." The research suggests that changing the shape of cancer cells, either
mechanically, chemically or genetically, could help tip the balance
against the tumor by using the inflammatory response in the body's own
immune system to fight cancer.
In their work, the team has focused on the activity of a protein
called nuclear factor kappa B (NF-kappaB), a key player in inflammation.
There is a lot of evidence that this protein misbehaves in many cancers, it sends out signals that promote survival of the cell, and that
suppressing it stops cancer cells proliferating.
However, the researchers note that while we know a lot about the
signaling events surrounding the aberrant behavior of NF-kappaB, we know
little about how the physical properties of the cell itself and its
environment might affect it.
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment